Mideast Conflict Disrupts Pharma Supply Chain

Key Supply Routes Under Threat

Conflict in the Middle East is severely disrupting critical air cargo routes, jeopardizing the supply of temperature-sensitive medicines, including vital cancer drugs, to the Gulf region. Pharmaceutical companies are urgently seeking alternative routes as major air hubs remain closed.

Overview of the Disruption

Major airports in Dubai, Abu Dhabi, and Doha, which are crucial logistics hubs for cargo between Europe, Asia, and Africa, have been impacted. According to industry data, over one-fifth of global air cargo is exposed to these disruptions. Companies are now rerouting flights through other airports in Saudi Arabia, Turkey, and Oman, resorting to overland trucking to complete deliveries.

Impact on the Pharmaceutical Market

The rerouting has led to longer transit times and increased transportation costs. The primary concern is for medicines requiring strict cold-chain storage, as prolonged journeys threaten their efficacy. Experts warn that supplies of critical drugs with short shelf lives, particularly oncology treatments like monoclonal antibodies, are at high risk. Some healthcare providers report they could face shortages within four to six weeks if the situation does not improve.

Outlook and Mitigation

While logistics providers are currently managing by prioritizing healthcare shipments and utilizing alternative land and air corridors, the industry faces mounting pressure. A prolonged conflict could lead to significant supply shortages in the Gulf and Asia, affecting not just finished medicines but also essential components like vial stoppers and packaging materials.

FAQ

Q: Which medicines are most at risk from the supply chain disruption?
A: Temperature-sensitive treatments with short shelf lives, such as certain cancer drugs and monoclonal antibodies, are at the highest risk due to the need for strict cold-chain logistics.

Q: How are companies adapting to the logistical challenges?
A: Companies are rerouting flights through alternative airports in Saudi Arabia and Oman and using overland transport to ensure medicines reach their final destinations.

Source: Investing.com